Esperion Therapeutics, Inc. (ESPR)
Since Aug 12, 2013, Esperion Therapeutics, Inc. (ESPR) has reported earnings 50 times. On average the shares move ±7.40% post-earnings, with a positive reaction 66.0% of the time. Its largest post-earnings gain was +15.41% (Aug 08, 2017) and its largest decline was -35.11% (May 02, 2018). The next earnings report is predicted for 2026-11-06 (approximate).
Earnings reactions
How ESPR moved on each past earnings report.
Earnings Impact
Total Earnings
50
Avg Abs. Movement
±7.40%
Positive %
66.0%
Negative %
34.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Mar 10, 2026 | ☀ PRE | -11.18% | open_in_new |
| Nov 06, 2025 | ☀ PRE | -14.97% | open_in_new |
| Aug 05, 2025 | ☀ PRE | +8.72% | open_in_new |
| May 06, 2025 | ☀ PRE | -6.67% | open_in_new |
Earnings Count
50
Total earnings in dataset
Avg Abs. Movement
±7.40%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G | 20260813 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260731 | open_in_new SEC.gov |
| 15-12G | 20260723 | open_in_new SEC.gov |
| EFFECT | 20260715 | open_in_new SEC.gov |
| EFFECT | 20260715 | open_in_new SEC.gov |
| EFFECT | 20260715 | open_in_new SEC.gov |
| EFFECT | 20260715 | open_in_new SEC.gov |
| EFFECT | 20260715 | open_in_new SEC.gov |
| EFFECT | 20260715 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260714 | open_in_new SEC.gov |
Frequently asked about ESPR earnings
When does Esperion Therapeutics, Inc. report earnings next? expand_more
Esperion Therapeutics, Inc. (ESPR)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ESPR stock move after earnings? expand_more
Over 50 reports, ESPR has moved an average of ±7.40% the session after earnings, closing higher 66.0% of the time.
What was ESPR's biggest post-earnings move? expand_more
ESPR's largest post-earnings gain on record was +15.41% on Aug 08, 2017, and its largest decline was -35.11% on May 02, 2018.
Where can I find Esperion Therapeutics, Inc.'s SEC filings? expand_more
All of Esperion Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right